MicroRNAs as the critical regulators of Doxorubicin resistance in breast tumor cells
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNAs as the critical regulators of Doxorubicin resistance in breast tumor cells
Authors
Keywords
-
Journal
Cancer Cell International
Volume 21, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-04-15
DOI
10.1186/s12935-021-01873-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR-135b-5p enhances doxorubicin-sensitivity of breast cancer cells through targeting anterior gradient 2
- (2019) Ying Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- miRNA-192-5p impacts the sensitivity of breast cancer cells to doxorubicin via targeting peptidylprolyl isomerase A
- (2019) Yi Zhang et al. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
- Dual-Targeting of miR-124-3p and ABCC4 Promotes Sensitivity to Adriamycin in Breast Cancer Cells
- (2019) Di Hu et al. Genetic Testing and Molecular Biomarkers
- miR3609 sensitizes breast cancer cells to adriamycin by blocking the programmed death-ligand 1 immune checkpoint
- (2019) Duolu Li et al. EXPERIMENTAL CELL RESEARCH
- MiR-202-5p/PTEN mediates doxorubicin-resistance of breast cancer cells via PI3K/Akt signaling pathway
- (2019) Tao Liu et al. CANCER BIOLOGY & THERAPY
- Role of MAML1 in targeted therapy against the esophageal cancer stem cells
- (2019) Meysam Moghbeli et al. Journal of Translational Medicine
- MicroRNA-222 promotes drug resistance to doxorubicin in breast cancer via regulation of miR-222/bim pathway
- (2019) Hong Dai et al. BIOSCIENCE REPORTS
- MiR-124 reversed the doxorubicin resistance of breast cancer stem cells through STAT3/HIF-1 signaling pathways
- (2019) Cong Liu et al. CELL CYCLE
- circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer
- (2019) Yiran Liang et al. ONCOGENE
- MicroRNA-140 impedes DNA repair by targeting FEN1 and enhances chemotherapeutic response in breast cancer
- (2019) Xiao Lu et al. ONCOGENE
- Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response
- (2019) Shu Lin et al. Cell Death & Disease
- Suppression of nicotinamide phosphoribosyltransferase expression by miR-154 reduces the viability of breast cancer cells and increases their susceptibility to doxorubicin
- (2019) Zahra Bolandghamat Pour et al. BMC CANCER
- MicroRNA-132 and microRNA-212 mediate doxorubicin resistance by down-regulating the PTEN-AKT/NF-κB signaling pathway in breast cancer
- (2018) Manxin Xie et al. BIOMEDICINE & PHARMACOTHERAPY
- miR-140-5p inhibits the proliferation and enhances the efficacy of doxorubicin to breast cancer stem cells by targeting Wnt1
- (2018) Dawei Wu et al. CANCER GENE THERAPY
- Cancer stem cell in breast cancer therapeutic resistance
- (2018) Xupeng Bai et al. CANCER TREATMENT REVIEWS
- Linc00518 Contributes to Multidrug Resistance Through Regulating the MiR-199a/MRP1 Axis in Breast Cancer
- (2018) Liang Chang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- miR-613 inhibits cell migration and invasion by downregulating Daam1 in triple-negative breast cancer
- (2018) Huaping Xiong et al. CELLULAR SIGNALLING
- Crosstalk between Notch, HIF-1α and GPER in Breast Cancer EMT
- (2018) Ernestina De Francesco et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MiR-770 suppresses the chemo-resistance and metastasis of triple negative breast cancer via direct targeting of STMN1
- (2018) Yaming Li et al. Cell Death & Disease
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- WNT and NOTCH signaling pathways as activators for epidermal growth factor receptor in esophageal squamous cell carcinoma
- (2018) Mohammad Reza Abbaszadegan et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- miR-381 induces sensitivity of breast cancer cells to doxorubicin by inactivation of MAPK signaling via FYN
- (2018) Hailong Mi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Suppression of Breast Cancer Stem Cells and Tumor Growth by the RUNX1 Transcription Factor
- (2018) Deli Hong et al. MOLECULAR CANCER RESEARCH
- FSTL1 enhances chemoresistance and maintains stemness in breast cancer cells via integrin β3/Wnt signaling under miR-137 regulation
- (2018) Shaoqiang Cheng et al. CANCER BIOLOGY & THERAPY
- The microRNA miR-181c enhances chemosensitivity and reduces chemoresistance in breast cancer cells via down-regulating osteopontin
- (2018) Baojuan Han et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway
- (2017) Hongyu Shen et al. GENE
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
- (2017) Tsukasa Shibue et al. Nature Reviews Clinical Oncology
- miR-93 and PTEN: Key regulators of doxorubicin-resistance and EMT in breast cancer
- (2017) Shihua Chu et al. ONCOLOGY REPORTS
- Loss of DPC4/SMAD4 expression in primary gastrointestinal neuroendocrine tumors is associated with cancer-related death after resection
- (2017) Christina L. Roland et al. SURGERY
- miR-214 promotes apoptosis and sensitizes breast cancer cells to doxorubicin by targeting the RFWD2-p53 cascade
- (2016) Jiaxuan Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Extracellular nicotinamide phosphoribosyltransferase, a new cancermetabokine
- (2016) Ambra A Grolla et al. BRITISH JOURNAL OF PHARMACOLOGY
- Long non-coding RNAs in cancer drug resistance development
- (2016) Maryam Majidinia et al. DNA REPAIR
- MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway
- (2016) Hongyu Shen et al. GENE
- MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1)
- (2016) Lin Zhao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- PD-1–PD-L1 immune-checkpoint blockade in B-cell lymphomas
- (2016) Aaron Goodman et al. Nature Reviews Clinical Oncology
- MicroRNA-3646 Contributes to Docetaxel Resistance in Human Breast Cancer Cells by GSK-3β/β-Catenin Signaling Pathway
- (2016) Xiaohui Zhang et al. PLoS One
- miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer
- (2016) Y Hu et al. Cell Death & Disease
- miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1
- (2016) Man Gao et al. Oncotarget
- A novel miR-34a target, protein kinase D1, stimulates cancer stemness and drug resistance through GSK3/β-catenin signaling in breast cancer
- (2016) Do Yeon Kim et al. Oncotarget
- Correlation of Wnt and NOTCH pathways in esophageal squamous cell carcinoma
- (2016) Meysam Moghbeli et al. Journal of Cell Communication and Signaling
- MicroRNA-134 modulates resistance to doxorubicin in human breast cancer cells by downregulating ABCC1
- (2015) Lin Lu et al. BIOTECHNOLOGY LETTERS
- miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer
- (2015) Yunhui Hu et al. BREAST CANCER RESEARCH AND TREATMENT
- A Systematic Review of Immunotherapy in Urologic Cancer: Evolving Roles for Targeting of CTLA-4, PD-1/PD-L1, and HLA-G
- (2015) Edgardo D. Carosella et al. EUROPEAN UROLOGY
- Osteopontin in Immune-mediated Diseases
- (2015) S.R. Rittling et al. JOURNAL OF DENTAL RESEARCH
- Targeting the DNA Damage Response in Cancer
- (2015) Mark J. O’Connor MOLECULAR CELL
- miR-181b promotes chemoresistance in breast cancer by regulating Bim expression
- (2015) YABING ZHENG et al. ONCOLOGY REPORTS
- Mechanisms of anterior gradient-2 regulation and function in cancer
- (2015) Veronika Brychtova et al. SEMINARS IN CANCER BIOLOGY
- EMT, CTCs and CSCs in tumor relapse and drug-resistance
- (2015) Abhisek Mitra et al. Oncotarget
- miR-193b Modulates Resistance to Doxorubicin in Human Breast Cancer Cells by Downregulating MCL-1
- (2015) Jingpei Long et al. Biomed Research International
- Role of Msi1 and PYGO2 in esophageal squamous cell carcinoma depth of invasion
- (2015) Meysam Moghbeli et al. Journal of Cell Communication and Signaling
- Involvement of miR-30c in resistance to doxorubicin by regulating YWHAZ in breast cancer cells
- (2015) Y. Fang et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- MiR-133a Is Functionally Involved in Doxorubicin-Resistance in Breast Cancer Cells MCF-7 via Its Regulation of the Expression of Uncoupling Protein 2
- (2015) Yuan Yuan et al. PLoS One
- TALEN-mediated Nanog disruption results in less invasiveness, more chemosensitivity and reversal of EMT in Hela cells
- (2015) Yan Ding et al. Oncotarget
- Breast cancer stem cells, EMT and therapeutic targets
- (2014) Srishti Kotiyal et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Targeting of miR34a-NOTCH1 Axis Reduced Breast Cancer Stemness and Chemoresistance
- (2014) E. Y. Park et al. CANCER RESEARCH
- The emergence of targeted drugs in breast cancer to prevent resistance to endocrine treatment and chemotherapy
- (2014) Eilin Austreid et al. EXPERT OPINION ON PHARMACOTHERAPY
- MiR-489 regulates chemoresistance in breast cancer via epithelial mesenchymal transition pathway
- (2014) Li Jiang et al. FEBS LETTERS
- Translational control of immune responses: from transcripts to translatomes
- (2014) Ciriaco A Piccirillo et al. NATURE IMMUNOLOGY
- Effect of Smad3/4 on chemotherapeutic drug sensitivity in colorectal cancer cells
- (2014) SUNG UNG MOON et al. ONCOLOGY REPORTS
- Intracellular osteopontin regulates homeostasis and function of natural killer cells
- (2014) Jianmei W. Leavenworth et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- p38α MAPK pathway: A key factor in colorectal cancer therapy and chemoresistance
- (2014) Valentina Grossi WORLD JOURNAL OF GASTROENTEROLOGY
- The ratio of Mcl-1 and Noxa determines ABT737 resistance in squamous cell carcinoma of the skin
- (2014) P Geserick et al. Cell Death & Disease
- The PTEN/PI3K/AKT Pathway in vivo, Cancer Mouse Models
- (2014) Amancio Carnero et al. Frontiers in Oncology
- Roles of microRNA-140 in stem cell-associated early stage breast cancer
- (2014) Benjamin Wolfson World Journal of Stem Cells
- Flap Endonuclease 1
- (2013) Lata Balakrishnan et al. Annual Review of Biochemistry
- The Formin Daam1 and Fascin Directly Collaborate to Promote Filopodia Formation
- (2013) Richa Jaiswal et al. CURRENT BIOLOGY
- Emerging role of nanog in tumorigenesis and cancer stem cells
- (2013) Luis E. IV Santaliz-Ruiz et al. INTERNATIONAL JOURNAL OF CANCER
- The Role of MicroRNAs in Breast Cancer Stem Cells
- (2013) Daniela Schwarzenbacher et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98
- (2013) Sherene Loi et al. JOURNAL OF CLINICAL ONCOLOGY
- miRNA-200c increases the sensitivity of breast cancer cells to doxorubicin through the suppression of E-cadherin-mediated PTEN/Akt signaling
- (2013) YONG CHEN et al. Molecular Medicine Reports
- Nanog, Pou5f1 and SoxB1 activate zygotic gene expression during the maternal-to-zygotic transition
- (2013) Miler T. Lee et al. NATURE
- The shaping and functional consequences of the microRNA landscape in breast cancer
- (2013) Heidi Dvinge et al. NATURE
- BIM: Enabling Sustainability and Asset Management through Knowledge Management
- (2013) Robbert Anton Kivits et al. TheScientificWorldJOURNAL
- MAWBP and MAWD inhibit proliferation and invasion in gastric cancer
- (2013) Dong-Mei Li WORLD JOURNAL OF GASTROENTEROLOGY
- MicroRNA-34a Modulates Chemosensitivity of Breast Cancer Cells to Adriamycin by Targeting Notch1
- (2012) Xiu-juan Li et al. ARCHIVES OF MEDICAL RESEARCH
- Molecular Pathways: Next-Generation Immunotherapy--Inhibiting Programmed Death-Ligand 1 and Programmed Death-1
- (2012) D. S. Chen et al. CLINICAL CANCER RESEARCH
- The estrogen-responsive Agr2 gene regulates mammary epithelial proliferation and facilitates lobuloalveolar development
- (2012) Suman Verma et al. DEVELOPMENTAL BIOLOGY
- Expression of the MAP kinase phosphatase DUSP4 is associated with microsatellite instability in colorectal cancer (CRC) and causes increased cell proliferation
- (2012) Benedikt Gröschl et al. INTERNATIONAL JOURNAL OF CANCER
- α2β1 Integrin Promotes Chemoresistance against Doxorubicin in Cancer Cells through Extracellular Signal-regulated Kinase (ERK)
- (2012) Dalila Naci et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dvl2-Dependent Activation of Daam1 and RhoA Regulates Wnt5a-Induced Breast Cancer Cell Migration
- (2012) Yichao Zhu et al. PLoS One
- miR-200c Sensitizes Breast Cancer Cells to Doxorubicin Treatment by Decreasing TrkB and Bmi1 Expression
- (2012) Florian Kopp et al. PLoS One
- MicroRNA-21 Modulates Chemosensitivity of Breast Cancer Cells to Doxorubicin by Targeting PTEN
- (2011) Zhao-Xia Wang et al. ARCHIVES OF MEDICAL RESEARCH
- Mechanism of Cell Adaptation
- (2011) Valentina Fodale et al. CANCER JOURNAL
- Chromosomal Instability Confers Intrinsic Multidrug Resistance
- (2011) A. J. X. Lee et al. CANCER RESEARCH
- Protein kinase D: coupling extracellular stimuli to the regulation of cell physiology
- (2011) Ya Fu et al. EMBO REPORTS
- MicroRNA 34c Gene Down-regulation via DNA Methylation Promotes Self-renewal and Epithelial-Mesenchymal Transition in Breast Tumor-initiating Cells
- (2011) Fengyan Yu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The expression of Mcl-1 in human cervical cancer and its clinical significance
- (2011) Ting Zhang et al. MEDICAL ONCOLOGY
- MiR-101 and Mcl-1 in non-small-cell lung cancer: expression profile and clinical significance
- (2011) Liang Luo et al. MEDICAL ONCOLOGY
- Down-regulation of microRNA-200c is associated with drug resistance in human breast cancer
- (2011) Junqing Chen et al. MEDICAL ONCOLOGY
- The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop
- (2011) A. Menssen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Integrin β3 and its ligand regulate the expression of uPA through p38 MAPK in breast cancer
- (2010) RUI WANG et al. APMIS
- NANOG induction of fetal liver kinase-1 (FLK1) transcription regulates endothelial cell proliferation and angiogenesis
- (2010) E. E. Kohler et al. BLOOD
- Fyn
- (2010) Yoshihito D. Saito et al. CANCER
- Emerging Roles for Natural MicroRNA Sponges
- (2010) Margaret S. Ebert et al. CURRENT BIOLOGY
- Intracellular osteopontin (iOPN) and immunity
- (2010) Makoto Inoue et al. IMMUNOLOGIC RESEARCH
- Overexpression of osteopontin in hepatocellular carcinoma and its relationships with metastasis, invasion of tumor cells
- (2010) Fan Lin et al. MOLECULAR BIOLOGY REPORTS
- Multiple Drug Resistance Mechanisms in Cancer
- (2010) Bruce C. Baguley MOLECULAR BIOTECHNOLOGY
- A Novel Small-Molecule Inhibitor of Protein Kinase D Blocks Pancreatic Cancer Growth In vitro and In vivo
- (2010) K. B. Harikumar et al. MOLECULAR CANCER THERAPEUTICS
- Functional regulation of FEN1 nuclease and its link to cancer
- (2010) L. Zheng et al. NUCLEIC ACIDS RESEARCH
- miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion
- (2009) Hongping Xia et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Integrins
- (2009) Malgorzata Barczyk et al. CELL AND TISSUE RESEARCH
- Function and Antagonism of β Integrins in the Development of Cancer Therapy
- (2009) H. Sheldrake et al. CURRENT CANCER DRUG TARGETS
- Histological and molecular types of breast cancer: is there a unifying taxonomy?
- (2009) Britta Weigelt et al. Nature Reviews Clinical Oncology
- Smad, PI3K/Akt, and Wnt-Dependent Signaling Pathways Are Involved in BMP-4-Induced ESC Self-Renewal
- (2009) Min Young Lee et al. STEM CELLS
- The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
- (2008) S.-M. Park et al. GENES & DEVELOPMENT
- The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional RepressorsZEB1andZEB2
- (2008) Manav Korpal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin
- (2008) O. Kovalchuk et al. MOLECULAR CANCER THERAPEUTICS
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
- (2008) Philip A. Gregory et al. NATURE CELL BIOLOGY
- Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?
- (2008) Witold Filipowicz et al. NATURE REVIEWS GENETICS
- Modified glutamine catabolism in macrophages of Ucp2 knock-out mice
- (2007) Tobias Nübel et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- The BCL-2 protein family: opposing activities that mediate cell death
- (2007) Richard J. Youle et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started